ArticleUpdates in surgery2026
Robotic surgical management of gallbladder cancer: comparing outcomes and feasibility of hepatectomy with or without bile duct resection and reconstruction.
Article in Updates in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionGallbladder cancer (GBC) is an aggressive malignancy, with surgery being the only curative option for resectable cases. Surgical approaches vary based on disease stage, ranging from cholecystectomy to extended liver resection and lymphadenectomy, with or without biliary resection. This study presents our experience of robotic surgery for GBC with and without biliary resection/reconstruction.
methodsA retrospective analysis was conducted on 38 patients who underwent robotic resection for GBC between February 2016 and November 2024. Beyond the standard partial segment 4B/5 resection and portal lymphadenectomy, the cohort was divided into two groups: common bile duct (CBD) resection and non-CBD resection group. Data are presented as median (mean ± SD).
resultsThe median age was 68 years (68 ± 11.49), with 71% women. Nineteen patients (50%) were diagnosed incidentally and required subsequent liver resection. Bile duct resection and Roux-en-Y hepaticojejunostomy were performed in 9 patients (23.7%), due to positive cystic duct margins. No conversions to open surgery occurred. Operative time was longer in the CBD resection group (470 vs. 219 min), which also had higher rates of vascular resection (33% vs. 3%), lymphovascular invasion (67% vs. 28%), and node-positive disease (67% vs. 24%), though the latter was not statistically significant. No differences were found in lymph node retrieval [6 (6.21 ± 4.58)], R0 resection rates (95%) or postoperative morbidity.
conclusionThe higher rates of lymphovascular invasion, vascular resections, and node-positive disease in the CBD resection group likely reflect more advanced disease. Robotic approach for GBC resection is feasible and safe, even when biliary and vascular resections are needed, offering an alternative minimally invasive technique to conventional open surgery.
Indexed as
Identifiers
41934591What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.